IDEAYA Biosciences
Erin Chui is a seasoned finance professional currently serving as Senior Manager of Financial Planning Analysis at IDEAYA Biosciences since September 2023. Previously, Erin held the position of Finance Manager at Nektar Therapeutics from October 2020 to August 2023 and worked in Business Strategy Finance at Kaiser Permanente from May 2018 to October 2020. Erin’s career began at PwC, where contributions as an Experienced Associate in the Assurance sector focused on Consumer Industrial Products & Services. Further experience includes roles at Novogradac & Company LLP in the Renewable Energy sector, as well as positions as an Accounting Associate at Shoreline Surgical and DW Investment Group, Inc. Erin started the journey with a Bachelor of Arts in Business Economics & Accounting from UC Irvine and gained international exposure at the University of Sussex.
This person is not in any teams
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California